Reduced Hypoglycemia Risk in Type 2 Diabetes Patients Switched to/Initiating Insulin Glargine 300 vs 100 U/ml: A European Real-World Study

INTRODUCTION: Randomized controlled trials and real-world data from the USA have shown similar glycemic control with insulin glargine 300 U/ml (Gla-300) and insulin glargine 100 U/ml (Gla-100) and reduced hypoglycemia risk with Gla-300. This real-world study describes the efficacy and safety of Gla-...

Descripción completa

Detalles Bibliográficos
Autores principales: Escalada, Javier, Bonnet, Fabrice, Wu, Jasmanda, Bonnemaire, Mireille, Gupta, Shaloo, Cambron-Mellott, Janelle M., Nicholls, Charlie, Müller-Wieland, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444406/
https://www.ncbi.nlm.nih.gov/pubmed/32681460
http://dx.doi.org/10.1007/s12325-020-01436-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444406/
https://www.ncbi.nlm.nih.gov/pubmed/32681460
http://dx.doi.org/10.1007/s12325-020-01436-5

Ejemplares similares